Sartorius AG (SRT3d)

CBOE (Germany)Healthcare

€253.4
-€0.75 (-0.3%)
Last close

January 21, 2026 at 16:30 UTC

Interactive Chart
SRT3d
1H
3H
6H
12H
1D
1W
1M
3M
6M
12M (YTD)
2Y
5Y
All
About Sartorius AG

Name

Sartorius AG

CEO

Michael Grosse

Industry

Healthcare

Year Founded

1990

Employees

13,573

Sartorius AG is a life science company that supplies equipment and consumables for bioprocessing and laboratory workflows. The portfolio supports steps from cell cultivation to purification and quality control, and it is designed to fit regulated environments where validation and documentation are central. Customers include biopharma developers, contract manufacturers, and research institutions that operate under strict standards. Operations are global with manufacturing, applications support, and service teams that follow a common quality system. The company participates in the healthcare and information technology ecosystem where hardware, software, and data must work together. Over time Sartorius AG expanded its installed base through product platforms that can scale from pilot to commercial production while keeping methods comparable.

Analyst Ratings
Consensus Recommendation
Analyst consensus: 8 Buy, 10 Hold, 6 Sell
Buy8
Hold10
Sell6
Fundamentals & Financials
Revenue (TTM)
€3.5B
Net Income (TTM)
€169.2M
EPS (TTM)
€1.93
ROA (TTM)
1.76%
Current Ratio
0.95
Dividend Yield
0.1%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement (Quarterly)
ItemQ3 2025
Revenue€843,200K
Cost of Sales€450,000K
Gross Profit€393,200K
Operating Income€147,700K
Net Income€43,800K
EPS€0.63
Technical Indicators

Sartorius AG's Technical Indicators Summary

As of the current session, SRT3.DE is exhibiting a neutral technical profile, reflected by a moderate ADX indicating limited trend strength and mixed momentum signals with the RSI near midpoint and MACD holding steady. The price is trading below key short- and medium-term moving averages but remains comfortably above the 200-day averages, suggesting a balance between shorter-term weakness and longer-term support. Volatility, measured by ATR, is moderate, while volume indicators like OBV and VWAP lean slightly bullish, supporting the current price level around 250.6 euros. The price sits just below the classic pivot point, which aligns with a neutral stance. Overall, the chart shows no decisive directional bias at this time.

Buy
8 signals
Neutral
10 signals
Sell
6 signals
Overall: Neutral42% Neutral signals
IndicatorValue
RSI (14)
48.28
Stochastic %K (14, 3, 3)
45.51
CCI (20)
-36.00
WPR (14)
-73.39
Momentum (10)
-14.30
MFI
59.28
MACD Level (12, 26)
3.06
Bollinger Bands
$237.95 - $268.88
ATR (14)
$6.92 (2.76%)
ADX (14)
16.07
OBV
-1,286,035
VWAP
$249.64
Classic Pivot Point
$253.10
Fibonacci Pivot Point
$253.10
Simple Moving Averages
$218.63 - $258.38(5 indicators)
Exponential Moving Averages
$229.59 - $255.70(5 indicators)
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.

Today's Snapshot

End-of-day levels show SRT3.DE only marginally weaker, with a -0.118% gap down from yesterday and a close near 254.10. Into the bell, a soft sector rise of 1.12% left a constructive backdrop for SRT3.DE. SRT3.DE remains stable amid a soft sector rise and limited recent news impacting its outlook.

Price Change

from €254.4 close

€-0.3

Trading Volume

Below avg (73.8K)

32.8K

vs S&P 500 Today

Underperforming Market

-1.42%

52-Week Position

Upper range

69.9%

Updated: January 21, 2026 at 16:04 UTC

Quote Summary
OpenPrevious Close
€256€254.4
Day Range52 Week Range
€246.1 - €256.7€166.05 - €292
VolumeAvg. Volume
93.3K77.1K
Market CapP/E Ratio
€17.4B130.8